...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

Would that modest 30% reduction change with a change in dosing, both amount and number of times a day?

At time like this I'm glad I have a reasonable level of ignorance in the science. I know from past investments that I've made where I had little or no understanding of how or what the scientests were doing made me boatloads of $$$.

tada

Share
New Message
Please login to post a reply